Search

everythinglearnresearchcommunity

for

Search:↓

Most adverse reactions to the treatment were mild, with nausea being the most common.

New compounds were made that are promising for prostate cancer therapy.

We need better ways to test and understand SARMs to make safer and more effective treatments.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

SARMs work differently in tissues due to unique interactions and structures.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

A new method was developed to make finasteride for treating hair loss.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Adenosine helps grow thicker hair in Japanese men with hair loss.